p53 and autophagy in colorectal cancer : function mechanism and Therapeutic applications
p53 和结直肠癌中的自噬:功能机制和治疗应用
基本信息
- 批准号:23591966
- 负责人:
- 金额:$ 3.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 2013
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Autophagy is a celluar response to adverse environment and stress. Recent evidence suggests that tumor cells induce autophagy during treatment of anticancer drugs. However, the effect of these events on cancer is not known. The aime was to evaluate the effect of p53 status and autophagy activity on the chemosensitivity of colorectal cancer.1.Autophagy was induced in response to DNA damage in p53 wild-type and p53 knockdown(p53-KD) colorectal cancer cells. The accumulation of LC-II was more intense in p53-KD cell than that in p53-cont cell. Furtheremore, we confirmed that apoptosis was induced in response to DNA damage in p53-cont and p53-KD cells after treating with siATG5. Apoptosis in p53-KD cell was less than that in p53-cont cell.2.Immunohistochemical staining of resected liver tumor revealed that hte expression of some autophagic related protein(Protein A) was markedly decreased. Patients in high Protein A expression group was associated with lymphphatic invation.
自噬是细胞对不利环境和压力的反应。最近的证据表明,肿瘤细胞在抗癌药物治疗过程中会诱导自噬。然而,这些事件对癌症的影响尚不清楚。目的探讨p53状态和自噬活性对结直肠癌化疗敏感性的影响。1.p53野生型和p53敲低(p53-KD)结直肠癌细胞中DNA损伤诱导自噬。 LC-II在p53-KD细胞中的积累比在p53-cont细胞中更强烈。此外,我们证实,用siATG5处理后,p53-cont和p53-KD细胞中的DNA损伤会诱导细胞凋亡。 p53-KD细胞的凋亡较p53-cont细胞少。2.免疫组化染色显示切除的肝脏肿瘤中一些自噬相关蛋白(Protein A)的表达明显减少。 Protein A高表达组患者与淋巴管炎症相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival
- DOI:10.1245/s10434-014-3577-x
- 发表时间:2014-06-01
- 期刊:
- 影响因子:3.7
- 作者:Beppu, Toru;Miyamoto, Yuji;Baba, Hideo
- 通讯作者:Baba, Hideo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYAMOTO Yuji其他文献
MIYAMOTO Yuji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIYAMOTO Yuji', 18)}}的其他基金
Visceral obesity impacts on adipokine expression and cancer recurrence in patients with colorectal cancer
内脏肥胖对结直肠癌患者脂肪因子表达和癌症复发的影响
- 批准号:
26462020 - 财政年份:2014
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on seismic isolated foundation and its input mechanism for extreme earthquake
隔震地基及其极端地震输入机制研究
- 批准号:
22360226 - 财政年份:2010
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Biosynthetic and functional analysis of mycobacterial glycolipid
分枝杆菌糖脂的生物合成及功能分析
- 批准号:
20790347 - 财政年份:2008
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Establishment of totally endoscopic cardiac surgery using ZEUS surgical system
ZEUS手术系统建立全腔镜心脏手术
- 批准号:
15390412 - 财政年份:2003
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Unraveling the cooperative action of p53 and autophagy against kidney aging
揭示p53和自噬对抗肾脏衰老的协同作用
- 批准号:
21K16163 - 财政年份:2021
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Tgm2-p62-p53 complex and autophagy regulation mechanism in chronic kidney disease
Tgm2-p62-p53复合物及慢性肾脏病自噬调控机制
- 批准号:
21K08221 - 财政年份:2021
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The global analysis of molecules regulated by ubiquitien-proteasome in podocytes
足细胞泛素蛋白酶体调控分子的整体分析
- 批准号:
20K17241 - 财政年份:2020
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of combination immunotherapy using telomerase-targeted oncolytic virus against high-risk neuroblastoma
使用端粒酶靶向溶瘤病毒对抗高危神经母细胞瘤的联合免疫疗法的开发
- 批准号:
19K18054 - 财政年份:2019
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of CML eradicative therapy by regulating BCR-ABL subcellular localization
通过调节BCR-ABL亚细胞定位开发CML根除疗法
- 批准号:
19K08847 - 财政年份:2019
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)